Montelukast in hospitalized patients diagnosed with COVID-19

OBJECTIVE: Several therapeutic agents have been assessed for the treatment of COVID-19, but few approaches have been proven efficacious. Because leukotriene receptor antagonists, such as montelukast have been shown to reduce both cytokine release and lung inflammation in preclinical models of viral...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Asthma
Asıl Yazarlar: Khan, Ahsan R., Misdary, Christian, Yegya-Raman, Nikhil, Kim, Sinae, Narayanan, Navaneeth, Siddiqui, Sheraz, Salgame, Padmini, Radbel, Jared, Groote, Frank De, Michel, Carl, Mehnert, Janice, Hernandez, Caleb, Braciale, Thomas, Malhotra, Jyoti, Gentile, Michael A., Jabbour, Salma K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938648/
https://ncbi.nlm.nih.gov/pubmed/33577360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02770903.2021.1881967
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller